Christopher P. Childers

Christopher P. Childers

Auto-generated profile, based on publicly available information

Christopher P. Childers

Department of Surgery, University of Washington, Seattle, WA http://twitter.com/cchildersmd

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in JAMA Surgery
Verified
Journal Article
Closed access
PDF file
CCChristopher P. Childers
Christopher P. Childers
MMMelinda Maggard-Gibbons
Melinda Maggard-Gibbons
Importance Increasing value requires improving quality or decreasing costs. In surgery, estimates for the cost of 1 minute of operating room (OR) time vary widely. No benchmark exists for the cost of OR time, nor has there been a comprehensive assessment of what contributes to OR cost. Objectives To calculate the cost of 1 minute of OR time, assess cost by setting and facility characteristics, and ascertain the proportion of costs that are direct and indirect. Design, Setting, and Participants This cross-sectional and longitudinal analysis examined annual financial disclosure documents from all comparable short-term general and specialty care hospitals in California from fiscal year (FY) 2005 to FY2014 (N = 3044; FY2014, n = 302). The analysis focused on 2 revenue centers: (1) surgery and recovery and (2) ambulatory surgery. Main Outcomes and Measures Mean cost of 1 minute of OR time, stratified by setting (inpatient vs ambulatory), teaching status, and hospital ownership. The proportion of cost attributable to indirect and direct expenses was identified; direct expenses were further divided into salary, benefits, supplies, and other direct expenses. Results In FY2014, a total of 175 of 302 facilities (57.9%) were not for profit, 78 (25.8%) were for profit, and 49 (16.2%) were government owned. Thirty facilities (9.9%) were teaching hospitals. The mean (SD) cost for 1 minute of OR time across California hospitals was $37.45 ($16.04) in the inpatient setting and $36.14 ($19.53) in the ambulatory setting (P = .65). There were no differences in mean expenditures when stratifying by ownership or teaching status except that teaching hospitals had lower mean (SD) expenditures than nonteaching hospitals in the inpatient setting ($29.88 [$9.06] vs $38.29 [$16.43];P = .006). Direct expenses accounted for 54.6% of total expenses ($20.40 of $37.37) in the inpatient setting and 59.1% of total expenses ($20.90 of $35.39) in the ambulatory setting. Wages and benefits accounted for approximately two-thirds of direct expenses (inpatient, $14.00 of $20.40; ambulatory, $14.35 of $20.90), with nonbillable supplies accounting for less than 10% of total expenses (inpatient, $2.55 of $37.37; ambulatory, $3.33 of $35.39). From FY2005 to FY2014, expenses in the OR have increased faster than the consumer price index and medical consumer price index. Teaching hospitals had slower growth in costs than nonteaching hospitals. Over time, the proportion of expenses dedicated to indirect costs has increased, while the proportion attributable to salary and supplies has decreased. Conclusions and Relevance The mean cost of OR time is $36 to $37 per minute, using financial data from California’s short-term general and specialty hospitals in FY2014. These statewide data provide a generalizable benchmark for the value of OR time. Furthermore, understanding the composition of costs will allow those interested in value improvement to identify high-yield targets.

1 December 2017 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
CCChristopher P. Childers
Christopher P. Childers
KCKimberly K. Childers
Kimberly K. Childers
MMMelinda Maggard-Gibbons
Melinda Maggard-Gibbons
JMJames Macinko
James Macinko
Purpose: In the United States, 3.8 million women have a history of breast (BC) or ovarian cancer (OC). Up to 15% of cases are attributable to heritable mutations, which, if identified, provide critical knowledge for treatment and preventive care. It is unknown how many patients who are at high risk for these mutations have not been tested and how rates vary by risk criteria.Methods: We used pooled cross-sectional data from three Cancer Control Modules (2005, 2010, 2015) of the National Health Interview Survey, a national in-person household interview survey. Eligible patients were adult females with a history of BC and/or OC meeting select 2017 National Comprehensive Cancer Network eligibility criteria on the basis of age of diagnosis and family history. Outcomes included the proportion of individuals reporting a history of discussing genetic testing with a health professional, being advised to undergo genetic testing, or undergoing genetic testing for BC or OC.Results: Of 47,218 women, 2.7% had a BC history and 0.4% had an OC history. For BC, 35.6% met one or more select eligibility criteria; of those, 29.0% discussed, 20.2% were advised to undergo, and 15.3% underwent genetic testing. Testing rates for individual eligibility criteria ranged from 6.2% (relative with OC) to 18.2% (diagnosis ≤ 45 years of age). For OC, 15.1% discussed, 13.1% were advised to undergo, and 10.5% underwent testing. Using only four BC eligibility criteria and all patients with OC, an estimated 1.2 to 1.3 million individuals failed to receive testing.Conclusion: Fewer than one in five individuals with a history of BC or OC meeting select National Cancer Comprehensive Network criteria have undergone genetic testing. Most have never discussed testing with a health care provider. Large national efforts are warranted to address this unmet need.

1 June 2018 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
KCKimberly K. Childers
Kimberly K. Childers
MMMelinda Maggard-Gibbons
Melinda Maggard-Gibbons
JMJames Macinko
James Macinko
CCChristopher P. Childers
Christopher P. Childers
Up to 10% of cancers are attributable to inherited gene mutations, such as BRCA1/2 and those associated with Lynch syndrome.1 Identifying mutation carriers is critical for treatment decisions, cancer prevention, and early detection.2 Despite the importance of equal access to testing, there is some evidence for disparities by education level, insurance status, and race/ethnicity.3 Although carrier rates are equivalent between men and women, there may also be a gender disparity in testing.4 To date, however, epidemiological studies have largely focused on genetic testing in women and hereditary breast and ovarian cancer (HBOC).5 This study describes the US national distribution of genetic testing for hereditary cancer risk, identifies disparities, and assesses whether a gender gap in testing exists.

1 October 2019 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
CCChristopher P. Childers
Christopher P. Childers
JDJill Q. Dworsky
Jill Q. Dworsky
MRMarcia M. Russell
Marcia M. Russell
MMMelinda Maggard-Gibbons
Melinda Maggard-Gibbons
In 1992, Medicare transitioned physician compensation from a fee-based system to the resource-based relative value scale.1 Private insurers followed suit.2 Under the resource-based relative value scale, physician payments are determined by 3 components, the largest of which is physician work (51%) followed by practice expense (45%) and professional lability insurance (4%).3 Each component is assigned a numeric relative value unit (RVU), which is multiplied by a geographic practice cost index and a monetary conversion factor (in 2018, the factor was $36). The sum of these 3 components is the overall reimbursement for a given Current Procedural Terminology (CPT) code.3,4

17 November 2021 in BJS Open
Verified
Journal Article
Open access
PDF file
LYLinda Ye
Linda Ye
CCChristopher P Childers
Christopher P Childers
MVMichael de Virgilio
Michael de Virgilio
RSRivfka Shenoy
Rivfka Shenoy
MMMichael A Mederos
Michael A Mederos
MMMelinda Maggard-Gibbons
Melinda Maggard-Gibbons
Background: Robotic ventral hernia repair (VHR) has seen rapid adoption, but with limited data assessing clinical outcome or cost. This systematic review compared robotic VHR with laparoscopic and open approaches. Methods: This systematic review was undertaken in accordance with PRISMA guidelines. PubMed, MEDLINE, Embase, and Cochrane databases were searched for articles with terms relating to ‘robot-assisted’, ‘cost effectiveness’, and ‘ventral hernia’ or ‘incisional hernia’ from 1 January 2010 to 10 November 2020. Intraoperative and postoperative outcomes, pain, recurrence, and cost data were extracted for narrative analysis. Results: Of 25 studies that met the inclusion criteria, three were RCTs and 22 observational studies. Robotic VHR was associated with a longer duration of operation than open and laparoscopic repairs, but with fewer transfusions, shorter hospital stay, and lower complication rates than open repair. Robotic VHR was more expensive than laparoscopic repair, but not significantly different from open surgery in terms of cost. There were no significant differences in rates of intraoperative complication, conversion to open surgery, surgical-site infection, readmission, mortality, pain, or recurrence between the three approaches. Conclusion: Robotic VHR was associated with a longer duration of operation, fewer transfusions, a shorter hospital stay, and fewer complications compared with open surgery. Robotic VHR had higher costs and a longer operating time than laparoscopic repair. Randomized or matched data with standardized reporting, long-term outcomes, and cost-effectiveness analyses are still required to weigh the clinical benefits against the cost of robotic VHR.

1 June 2020 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
CCChristopher P. Childers
Christopher P. Childers
MMMelinda Maggard-Gibbons
Melinda Maggard-Gibbons
Compensation for physician specialties varies widely. In 2017, family practice physicians made a median $241 085 while neurosurgeons made $737 289.1 This pay gap is associated with declining interest in primary care despite increasing need.2,3 The work relative value unit (wRVU) scale is frequently indicated as a primary driver of this compensation difference,2,4-6 yet to our knowledge there are few empirical evaluations.7,8